Technetium Disofenin
Technetium disofenin (99mTc-DISIDA) is a hepatobiliary radiopharmaceutical that is taken up by hepatocytes via organic anion transport mechanisms and excreted into bile, enabling scintigraphic evaluation of hepatobiliary function and biliary tract patency. It is used in hepatobiliary imaging to assess conditions such as acute cholecystitis, biliary obstruction, and post-operative biliary leaks. The pattern of radiotracer uptake and excretion provides functional information about hepatocyte integrity and biliary flow.
Etki Mekanizması
Contains a radioactive isotope that accumulates in specific tissues or organs, enabling detection and imaging of physiological processes or pathological conditions using nuclear medicine techniques.
Pharmacokinetics (PK)
Pharmacodynamics (PD)
Contains a radioactive isotope that accumulates in specific tissues or organs, enabling detection and imaging of physiological processes or pathological conditions using nuclear medicine techniques.
HBD / HBA
- / -
No targets recorded
Target interaction data is not yet available for this drug.
No interactions recorded
Drug interaction data is not yet available for this compound.
No side effects recorded
Side effect data is not yet available for this drug.
Sıkça Sorulan Sorular
Technetium disofenin (99mTc-DISIDA) is a hepatobiliary radiopharmaceutical that is taken up by hepatocytes via organic anion transport mechanisms and excreted into bile, enabling scintigraphic evaluation of hepatobiliary function and biliary tract patency. It is used in hepatobiliary imaging to assess conditions such as acute cholecystitis, biliary obstruction, and post-operative biliary leaks. The pattern of radiotracer uptake and excretion provides functional information about hepatocyte integrity and biliary flow.
Contains a radioactive isotope that accumulates in specific tissues or organs, enabling detection and imaging of physiological processes or pathological conditions using nuclear medicine techniques.
Yes, Technetium Disofenin is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.
References & Data Sources
- ChEMBL — European Bioinformatics Institute (EBI). CHEMBL2110575. Open-access bioactivity database.
Data aggregated from publicly available pharmacological databases. Last updated 2026-02-27.
Embed This Widget
Add the script tag and a data attribute to embed this widget.
<script src="https://cdn.jsdelivr.net/npm/drugfyi-embed@1/dist/embed.min.js" defer></script>
<div data-drugfyi="drug" data-slug="technetium-disofenin"></div>
Embed via iframe for maximum compatibility.
<iframe src="https://drugfyi.com/iframe/drug/technetium-disofenin/" width="420" height="400" frameborder="0" style="border:0;border-radius:10px;max-width:100%" loading="lazy"></iframe>
Paste this URL in WordPress, Medium, or any oEmbed-compatible platform.
https://drugfyi.com/drug/technetium-disofenin/
Add a dynamic SVG badge to your README or docs.
[](https://drugfyi.com/drug/technetium-disofenin/)
Use the native HTML custom element.
<script src="https://cdn.jsdelivr.net/npm/drugfyi-embed@1/dist/embed.min.js" defer></script>
<drugfyi-drug slug="technetium-disofenin"></drugfyi-drug>